Learn More
Invitrogen™ CD272 (BTLA) Polyclonal Antibody

Description
Positive controls that may be used include: Jurkat Cell Lysate, Human Small Intestine Tissue Slide.
Specifications
Specifications
| Antigen | CD272 (BTLA) |
| Applications | Immunohistochemistry (Paraffin), Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% sodium azide |
| Gene | BTLA |
| Gene Accession No. | Q7Z6A9 |
| Gene Alias | A630002H24; B and T lymphocyte associated; B and T lymphocyte associated protein; B and T lymphocyte attenuator; B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein; BTLA; BTLA_HUMAN; BTLA1; CD272; CD272 antigen; FLJ16065; MGC129743 |
| Gene Symbols | BTLA |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.